Determinants of participation and quality of life of young adults with cerebral palsy: longitudinal approach and comparison with the general population - SPARCLE 3 study protocol.
Adulthood
Cerebral palsy
Employment
Health care
Participation
Quality of life
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
30 Jun 2021
30 Jun 2021
Historique:
received:
25
05
2020
accepted:
02
06
2021
entrez:
1
7
2021
pubmed:
2
7
2021
medline:
10
7
2021
Statut:
epublish
Résumé
Effective inclusion in society for young people with disabilities is increasingly seen as generating opportunities for self-development, and improving well-being. However, significant barriers remain in the vast majority of activities meaningful for young adults. Research argues that various personal (disabilities, health) and environmental (access to the resources needed, accessible environment, discrimination, lack of personal economic independence) factors contribute to limited participation. However, previous studies conducted in young people with cerebral palsy (CP) mainly investigated the transition period to adulthood, and did not fully consider the whole range of impairment severity profiles or environmental barriers. In this study, we will use the follow-up of the SPARCLE cohort and a comparison group from the general population (1) to investigate the impact of the environment on participation and quality of life of young adults with CP, (2) to determine predictors of a successful young adulthood in educational, professional, health and social fields, (3) to compare quality of life and frequency of participation in social, work and recreational activities with the general population, (4) to document on participation and quality of life in those with severe disabilities. The SPARCLE3 study has a combined longitudinal and cross-sectional design. Young adults with CP aged 22 to 27 years in 6 European regions previously enrolled in the SPARCLE cohort or newly recruited will be invited to self-complete a comprehensive set of questionnaires exploring participation (daily life and discretionary activities), health-related quality of life, body function, personal factors (health, personal resources), and contextual factors (availability of needed environmental items, family environment, services provision) during home visits supervised by trained researchers. Proxy-reports or adapted questionnaires will be used for those with the most severe impairments. The recruitment of a large group from the general population (online survey) will enable to identify life areas where the discrepancies between young people with CP and their able-bodied peers are the most significant. This study will help identify to what extent disabilities and barriers in environment negatively affect participation and quality of life, and how previous valued experiences during childhood or adolescence might modulate these effects.
Sections du résumé
BACKGROUND
BACKGROUND
Effective inclusion in society for young people with disabilities is increasingly seen as generating opportunities for self-development, and improving well-being. However, significant barriers remain in the vast majority of activities meaningful for young adults. Research argues that various personal (disabilities, health) and environmental (access to the resources needed, accessible environment, discrimination, lack of personal economic independence) factors contribute to limited participation. However, previous studies conducted in young people with cerebral palsy (CP) mainly investigated the transition period to adulthood, and did not fully consider the whole range of impairment severity profiles or environmental barriers. In this study, we will use the follow-up of the SPARCLE cohort and a comparison group from the general population (1) to investigate the impact of the environment on participation and quality of life of young adults with CP, (2) to determine predictors of a successful young adulthood in educational, professional, health and social fields, (3) to compare quality of life and frequency of participation in social, work and recreational activities with the general population, (4) to document on participation and quality of life in those with severe disabilities.
METHODS
METHODS
The SPARCLE3 study has a combined longitudinal and cross-sectional design. Young adults with CP aged 22 to 27 years in 6 European regions previously enrolled in the SPARCLE cohort or newly recruited will be invited to self-complete a comprehensive set of questionnaires exploring participation (daily life and discretionary activities), health-related quality of life, body function, personal factors (health, personal resources), and contextual factors (availability of needed environmental items, family environment, services provision) during home visits supervised by trained researchers. Proxy-reports or adapted questionnaires will be used for those with the most severe impairments. The recruitment of a large group from the general population (online survey) will enable to identify life areas where the discrepancies between young people with CP and their able-bodied peers are the most significant.
DISCUSSION
CONCLUSIONS
This study will help identify to what extent disabilities and barriers in environment negatively affect participation and quality of life, and how previous valued experiences during childhood or adolescence might modulate these effects.
Identifiants
pubmed: 34193065
doi: 10.1186/s12883-021-02263-z
pii: 10.1186/s12883-021-02263-z
pmc: PMC8244176
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
254Subventions
Organisme : Agence Nationale de la Recherche
ID : 316684170
Organisme : Deutsche Forschungsgemeinschaft
ID : 316684170
Organisme : ALF Swedish governement
ID : ALFGBG-726001
Références
Dev Med Child Neurol. 2019 Feb;61(2):226-231
pubmed: 30194703
Dev Med Child Neurol. 2016 Jan;58(1):85-92
pubmed: 26330098
Dev Med Child Neurol. 2014 Mar;56(3):245-51
pubmed: 24344767
J Rehabil Med. 2019 Mar 13;51(3):167-174
pubmed: 30815703
Disabil Rehabil. 2011;33(1):36-50
pubmed: 20455710
Res Dev Disabil. 2014 Nov 14;36C:551-564
pubmed: 25462516
Chronobiol Int. 2015 Apr;32(3):428-40
pubmed: 25482053
Disabil Rehabil. 2014;36(1):1-9
pubmed: 23594053
Gut. 1999 Jan;44(1):77-80
pubmed: 9862829
Res Dev Disabil. 2017 Jan;60:277-284
pubmed: 27793550
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Qual Life Res. 2010 May;19(4):571-84
pubmed: 20217246
J Rehabil Med. 2007 Oct;39(8):605-11
pubmed: 17896051
BMC Health Serv Res. 2016 May 20;16:189
pubmed: 27206474
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
J Intellect Dev Disabil. 2013 Sep;38(3):215-22
pubmed: 23672634
J Pediatr Rehabil Med. 2014;7(1):53-61
pubmed: 24919938
Arch Phys Med Rehabil. 2017 Nov;98(11):2196-2205.e1
pubmed: 28427924
Dev Med Child Neurol. 2011 Aug;53(8):704-10
pubmed: 21707596
Dev Med Child Neurol. 2020 Mar;62(3):372-378
pubmed: 31777955
Disabil Rehabil. 2012;34(24):2103-10
pubmed: 22510161
BMJ. 2009 Apr 24;338:b1458
pubmed: 19395424
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep;17(5):520-4
pubmed: 16547687
Child Care Health Dev. 2019 Sep;45(5):613-622
pubmed: 31297831
Res Dev Disabil. 2013 Oct;34(10):3202-10
pubmed: 23891732
BMC Public Health. 2006 Apr 25;6:105
pubmed: 16638126
Dev Med Child Neurol. 2013 Nov;55(11):1000-8
pubmed: 23924262
Dev Med Child Neurol. 2017 Apr;59(4):367-373
pubmed: 27861776
Dev Med Child Neurol. 2009 May;51(5):389-96
pubmed: 19191835
Dev Med Child Neurol. 2000 Dec;42(12):816-24
pubmed: 11132255
Qual Life Res. 2004 Mar;13(2):299-310
pubmed: 15085902
Curr Opin Neurol. 2008 Apr;21(2):136-42
pubmed: 18317270
Dev Med Child Neurol. 2007 Apr;49(4):265-9
pubmed: 17376136
J Rehabil Med. 2010 Jun;42(6):528-35
pubmed: 20549157
Occup Environ Med. 2019 Mar;76(3):189-198
pubmed: 30635432
Pediatrics. 2016 Jan;137(1):
pubmed: 26659459
Phys Occup Ther Pediatr. 2017 Aug;37(3):239-251
pubmed: 27563732
Dev Med Child Neurol. 2010 Jun;52(6):576-82
pubmed: 20187888
Dev Med Child Neurol. 2013 Jun;55(6):509-19
pubmed: 23346889
Dev Med Child Neurol. 2014 Apr;56(4):323-8
pubmed: 24111874
BMC Psychol. 2016 Apr 08;4:16
pubmed: 27059602
Disabil Rehabil. 2011;33(1):28-35
pubmed: 20446803
Dev Neurorehabil. 2014 Aug;17(4):259-69
pubmed: 23869878
Qual Life Res. 2010 Dec;19(10):1487-500
pubmed: 20668950
Gesundheitswesen. 2017 Jun;79(6):491-496
pubmed: 26270040
BMJ Open. 2018 Aug 17;8(8):e020914
pubmed: 30121595
Eur J Public Health. 2015 Aug;25(4):673-7
pubmed: 25477131
Eur J Paediatr Neurol. 2014 May;18(3):282-94
pubmed: 24412031
Res Dev Disabil. 2013 Jan;34(1):588-95
pubmed: 23123872
Dev Med Child Neurol. 2017 Jul;59(7):762-768
pubmed: 28304081
Trials. 2019 Mar 19;20(1):176
pubmed: 30890152
Dev Med Child Neurol. 2005 Aug;47(8):571-6
pubmed: 16108461
BMC Public Health. 2019 Jun 26;19(1):831
pubmed: 31242889
BMC Med. 2018 Jul 23;16(1):111
pubmed: 30032726
Disabil Health J. 2016 Oct;9(4):673-81
pubmed: 27302534
Dev Med Child Neurol. 2008 Aug;50(8):618-24
pubmed: 18754901
BMC Public Health. 2010 May 26;10:280
pubmed: 20504349
Dev Med Child Neurol. 2017 Feb;59(2):174-182
pubmed: 27521188
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Clin Rehabil. 2000 Jun;14(3):300-6
pubmed: 10868725
Disabil Rehabil. 2015;37(24):2264-71
pubmed: 25738914
Arch Phys Med Rehabil. 2010 Jan;91(1):143-8
pubmed: 20103409
Arch Phys Med Rehabil. 2014 Nov;95(11):2029-39
pubmed: 24929026
Child Care Health Dev. 2013 Jul;39(4):500-11
pubmed: 23763251